Farmácia/Notícias da Indústria
Grupo do CDC afirma que ainda não há evidência sugerindo a necessidade de reforço da vacina contra Covid.
25 Jun, 2021 | 10:43hNo evidence yet to suggest Covid vaccine booster is needed, CDC group says – NBC News
Opinião relacionada: 7 Reasons Why We Should Not Need Boosters for COVID-19 – by Monica Ghandi, MD
Perspectiva | As vacinas chinesas contra COVID têm desempenho inferior? A escassez de estudos de vida real deixa questões sem respostas.
25 Jun, 2021 | 10:42hRelacionados: WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic. E Brazilian town experiment shows mass vaccination can wipe out COVID-19.
Opinião | As vacinas de mRNA são extraordinárias, mas a Novavax é ainda melhor.
25 Jun, 2021 | 10:41hThe mRNA Vaccines Are Extraordinary, but Novavax Is Even Better – The Atlantic
Comentário no Twitter
The tale of mRNA vaxes & new technology hype, & underestimating the importance of Novavax – a more old-school vaccine with efficacy just as high, & lower adverse events. My latest in @TheAtlantic https://t.co/Hid29G5mkC
— Hilda Bastian, PhD (@hildabast) June 24, 2021
Estudo randomizado | Doxiciclina por 7 dias é superior à dose única de azitromicina no tratamento da infecção retal por clamídia.
25 Jun, 2021 | 10:37hAzithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário:
Comentário no Twitter
Doxycycline is 20% more efficacious than azithromycin for the treatment of rectal chlamydia. Check out the results of our RCT published today in @NEJM.
Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis | NEJM https://t.co/qpjo8VTg8u
— Jane Hocking (@JHocking01) June 23, 2021
Painel consultivo do CDC apoia o uso da vacina contra dengue em áreas de alto risco, apesar dos desafios na distribuição.
25 Jun, 2021 | 10:33hMais um estudo mostra que uma dose única de vacina de mRNA tem efeito máximo em pacientes com infecção prévia.
24 Jun, 2021 | 11:07hPrimary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses – ACS Nano
Relacionado: France recommends single dose of vaccine if previous Covid infection detected. E [Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19. E Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19
Comentário no Twitter
Prior covid? Unless it's a severe case, one-dose mRNA vaccine adds considerable protection and nothing added by 2nd dose. This is now concordant w/ >20 studieshttps://t.co/8Qpuw193zk @acsnano pic.twitter.com/TJNbl8HPy9
— Eric Topol (@EricTopol) June 23, 2021
Relatório | Variantes do SARS-CoV-2 e vacinas.
24 Jun, 2021 | 11:06hSARS-CoV-2 Variants and Vaccines – New England Journal of Medicine
3 doses de vacina de mRNA contra Covid-19 em receptores de transplante de órgão sólido pode melhorar a imunogenicidade da vacina.
24 Jun, 2021 | 11:05hEfeitos da vacinação na transmissão domiciliar do SARS-CoV-2 na Inglaterra – “A probabilidade de transmissão domiciliar foi de aproximadamente 40 a 50% menor em familiares de pacientes-índice vacinados 21 dias ou mais antes do teste positivo do que os familiares de pacientes-índice não vacinados.”
24 Jun, 2021 | 11:04hRelacionados: Study in England showed one dose of COVID-19 vaccine can cut household transmission by up to half – This protection is on top of the reduced risk of a vaccinated person developing symptomatic infection, which is around 60 to 65% after the first dose E Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.
CDC | Vacinas de mRNA parecem ter ligação com casos de miocardite e pericardite – 1.226 casos de miocardite ou pericardite foram relatados, a maioria em pessoas com menos de 30 anos de idade.
24 Jun, 2021 | 11:00hVer também: Experts: mRNA COVID-19 vaccines likely tied to heart inflammation – CIDRAP
Relacionados: Case series: 7 cases of myocarditis following mRNA-based COVID-19 vaccination. E Case series: clinical and cardiac magnetic resonance imaging findings of 4 cases of myocarditis following mRNA-based COVID-19 vaccination. E Case series: symptomatic acute myocarditis in 7 adolescents following mRNA COVID-19 vaccination. E CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. E Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. E CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.